These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8774066)

  • 1. Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock.
    Nakae H; Endo S; Inada K; Yaegashi Y; Takakuwa T; Yamada Y; Arakawa N; Suzuki T; Taniguchi S; Shimamura T; Ogawa M; Teraoka H
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):131-9. PubMed ID: 8774066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis.
    Takakuwa T; Endo S; Nakae H; Suzuki T; Inada K; Yoshida M; Ogawa M; Uchida K
    Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):271-81. PubMed ID: 7938901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of type II phospholipase A2 and nitrite/nitrate in patients with burns.
    Yamada Y; Endo S; Kamei Y; Minato T; Yokoyama M; Taniguchi S; Nakae H; Inada K; Ogawa M
    Burns; 1998 Sep; 24(6):513-7. PubMed ID: 9776089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.
    Sörensen J; Kald B; Tagesson C; Lindahl M
    Intensive Care Med; 1994 Nov; 20(8):555-61. PubMed ID: 7706567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of inflammatory mediators in patients with generalized peritonitis.
    Kikuchi M; Endo S; Inada K; Inoue Y; Wakabayashi G; Ishikura H; Tanaka T
    J Med; 1999; 30(3-4):245-58. PubMed ID: 17312678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis.
    Endo S; Inada K; Yamashita H; Takakuwa T; Nakae H; Kasai T; Kikuchi M; Ogawa M; Uchida K; Yoshida M
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):289-95. PubMed ID: 8008978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAF acetylhydrolase and arachidonic acid metabolite levels in patients with sepsis.
    Takakuwa T; Endo S; Nakae H; Kikichi M; Inada K; Yoshida M
    Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):283-90. PubMed ID: 7938902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
    Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of inflammatory cytokines, nitrate/nitrite, type II phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome.
    Takakuwa T; Endo S; Inada K; Kasai T; Yamada Y; Ogawa M
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):43-52. PubMed ID: 9434314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation.
    Izaki S; Yamamoto T; Goto Y; Ishimaru S; Yudate F; Kitamura K; Matsuzaki M
    Br J Dermatol; 1996 Jun; 134(6):1060-4. PubMed ID: 8763425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mouse plasma PAF acetylhydrolase: I. Characterization and properties.
    Tsaoussis V; Vakirtzi-Lemonias C
    J Lipid Mediat Cell Signal; 1994 May; 9(3):301-15. PubMed ID: 7921789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activating factor and endotoxin increase the enzyme activity and gene expression of type II phospholipase A2 in the rat intestine. Role of polymorphonuclear leukocytes.
    Tan XD; Wang H; Gonzalez-Crussi FX; Chang H; Gonzalez-Crussi F; Hsueh W
    J Immunol; 1996 Apr; 156(8):2985-90. PubMed ID: 8609420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of type II phospholipase A2, cytokines and eicosanoids in patients with burns.
    Nakae H; Endo S; Inada K; Yamashita H; Yamada Y; Takakuwa T; Kasai T; Ogawa M; Uchida K
    Burns; 1995 Sep; 21(6):422-6. PubMed ID: 8554682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications.
    Wu A; Hinds CJ; Thiemermann C
    Shock; 2004 Mar; 21(3):210-21. PubMed ID: 14770033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of type II phospholipase A2 and platelet-activating factor on Mac-1 surface expression and exocytosis of gelatinase granules in human neutrophils: evidence for the 5-lipoxygenase-dependent mechanism.
    Takasaki J; Kawauchi Y; Masuho Y
    J Immunol; 1998 May; 160(10):5066-72. PubMed ID: 9590257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between plasma levels of type II phospholipase A2, PAF acetylhydrolase, endothelin-1, and thrombomodulin in patients with infected burns.
    Takakuwa T; Endo S; Nakae H; Yamada Y; Inada K; Yoshida M; Ogawa M; Uchida K
    Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):335-40. PubMed ID: 7712109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor and human thyroid cancer.
    Denizot Y; Chianéa T; Labrousse F; Truffinet V; Delage M; Mathonnet M
    Eur J Endocrinol; 2005 Jul; 153(1):31-40. PubMed ID: 15994743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor and human meningiomas.
    Denizot Y; De Armas R; Caire F; Pommepuy I; Truffinet V; Labrousse F
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):674-8. PubMed ID: 17083481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.
    Triggiani M; De Marino V; Sofia M; Faraone S; Ambrosio G; Carratù L; Marone G
    Am J Respir Crit Care Med; 1997 Jul; 156(1):94-100. PubMed ID: 9230731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.
    Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF
    J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.